Rezina Arju
Czech Academy of Sciences, Institute of Microbiology(CZ)
Publications by Year
Research Areas
Immune cells in cancer, PI3K/AKT/mTOR signaling in cancer, Cancer Immunotherapy and Biomarkers, Chemokine receptors and signaling, Cancer Cells and Metastasis
Most-Cited Works
- → A Hypoxia-Controlled Cap-Dependent to Cap-Independent Translation Switch in Breast Cancer(2007)301 cited
- → Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer(2009)244 cited
- → mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy(2017)171 cited
- → Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network(2019)159 cited
- → High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug Resistance(2010)59 cited
- → Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming(2017)58 cited
- → Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy(2015)54 cited
- → mTORC1 and -2 Coordinate Transcriptional and Translational Reprogramming in Resistance to DNA Damage and Replicative Stress in Breast Cancer Cells(2016)43 cited
- The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease.(2016)
- → Atypical ezrin localization as a marker of locally advanced breast cancer(2012)22 cited